RECLIMET OD 60MG

Reclimet OD 60 Tablet is classified as an anti-diabetic medication that combines two active components to manage type 2 diabetes mellitus in adult patients. This formulation aids in regulating blood glucose levels effectively in individuals diagnosed with diabetes. It is important to administer this medication alongside food and to maintain a consistent daily schedule for optimal therapeutic outcomes. Dosage should be determined by a healthcare provider, who may adjust it based on ongoing evaluations of the patient’s blood sugar levels. Continuing the treatment is crucial, even if one feels stable or has achieved appropriate glucose control. Discontinuing the medication without professional guidance may lead to elevated blood sugar levels, potentially resulting in severe complications such as renal impairment, vision loss, neuropathy, and amputation risks. It is essential to integrate this medication into a broader diabetes management plan that includes a balanced diet, consistent physical activity, and weight management as recommended by a healthcare professional. Lifestyle choices significantly affect diabetes management and treatment success. Users should be aware of signs of hypoglycemia, such as excessive sweating, dizziness, headaches, and trembling, and have a fast-acting glucose source on hand to counteract low blood sugar episodes. Alcohol consumption should be avoided due to its potential to lower blood sugar levels further. Other possible adverse effects may include alterations in taste perception, feelings of nausea, diarrhea, abdominal discomfort, headaches, and respiratory infections. Some individuals may also experience weight gain while on this medication. This medication should not be utilized by individuals with type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver dysfunction. Prior to starting the treatment, it is advisable to disclose any history of cardiovascular diseases to a healthcare provider, as this may influence eligibility for the medication. Pregnant and breastfeeding individuals should seek medical advice before use. Regular monitoring of blood glucose levels and periodic laboratory tests to assess blood cell counts and liver health may be recommended during treatment.